Point72 Hong Kong’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-782
Closed -$259K 2563
2022
Q1
$259K Buy
+782
New +$241K 0.01% 884
2021
Q4
Sell
-328
Closed -$107K 2568
2021
Q3
$107K Buy
+328
New +$111K ﹤0.01% 1328
2020
Q3
Sell
-1,833
Closed -$443K 1640
2020
Q2
$443K Buy
+1,833
New +$368K 0.05% 361
2019
Q4
Sell
-2
Closed 1536
2019
Q3
$0 Sell
2
-1,583
-100% -$342K ﹤0.01% 1452
2019
Q2
$413K Buy
1,585
+910
+135% +$241K 0.11% 153
2019
Q1
$193K Buy
+675
New +$224K 0.08% 187
2018
Q3
Sell
-136
Closed -$56K 1271
2018
Q2
$56K Buy
+136
New +$49.3K 0.02% 408
2018
Q1
Sell
-51
Closed -$10K 1223
2017
Q4
$10K Sell
51
-68
-57% -$12.7K 0.01% 499
2017
Q3
$20K Buy
119
+92
+341% +$13.9K 0.01% 391
2017
Q2
$4K Buy
+27
New +$3.63K ﹤0.01% 597
2017
Q1
Sell
-3,255
Closed -$367K 1074
2016
Q4
$367K Buy
3,255
+2,955
+985% +$342K 0.37% 69
2016
Q3
$39K Buy
+300
New +$35.9K 0.02% 502

Other funds holding ABMD

Point72 Hong Kong's ABMD Position: Q2 2022 in Review

Point72 Hong Kong sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 782 shares — an estimated $259K sold.

Point72 Hong Kong first reported a position in ABMD in Q3 2016 and held it in 12 quarters. The position peaked at $443K in Q2 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Point72 Hong Kong reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 782 Abiomed Inc shares in Q2 2022, an estimated $259K.
  • Point72 Hong Kong first reported a position in Abiomed Inc in Q3 2016 and held it in 12 quarters.
  • Point72 Hong Kong's Abiomed Inc position peaked at $443K in Q2 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.